Cluster 1: Salud
- Inicio
- |
- Subvenciones y créditos
- |
- Cluster 1: Salud
El pilar I es en donde se engloban los proyectos más competitivos, los clásicos proyectos colaborativos de anteriores Programas Marcos y que agrupan a investigadores, empresas, centros de investigación y universidades
Actuaciones subvencionables
- Medicina personalizada.
- Afecciones del medioambiente en la salud y como nosotros afectamos al medioambiente.
- Abordar el Plan de Salud Europeo “One Health” en contra de la resistencia microbiana.
- Enfermedades raras.
Name | Opening date | Next deadline | Deadline model | Link |
Financial support for Ecosystem Partners | 16/08/2023 | 14/11/2023 | single-stage | |
Safe & Sustainable by Design (SSbD) packaging and single use device solutions for healthcare products | 27/07/2023 | 08/11/2023, 23/04/2024 | two-stage | |
Sustainable circular development and manufacturing of healthcare products and their quantitative environmental impact assessment | 27/07/2023 | 08/11/2023, 23/04/2024 | two-stage | |
Patient-centric blood sample collection to enable decentralised clinical trials and improve access to healthcare | 27/07/2023 | 08/11/2023, 23/04/2024 | two-stage | |
Expanding translational knowledge in minipigs: a path to reduce and replace non-human primates in non-clinical safety assessment | 27/07/2023 | 08/11/2023, 23/04/2024 | two-stage | |
Inclusive clinical studies for equitable access to clinical research in Europe | 27/07/2023 | 08/11/2023, 23/04/2024 | two-stage | |
: Establishing novel approaches to improve clinical trials for rare and ultra-rare diseases | 27/07/2023 | 08/11/2023, 23/04/2024 | two-stage | |
Mission Ocean and Waters and Mission A Soil Deal for Europe – Joint demonstration of approaches and solutions to address nutrient pollution in the landscape-river-sea system in the Mediterranean sea basin | 17 January 2023 | 20 Sep. 2023 | single-stage | |
European Partnership on Rare Diseases | 12 January 2023 | 19 Sep. 2023 | single-stage | |
Mission Climate adaptation, Mission Ocean & waters and Mission Soil Deal for Europe – Joint demonstration of an integrated approach to increasing landscape water retention capacity at regional scale | 17 January 2023 | 20 Sep. 2023 | single-stage | |
Towards a holistic support to children and adolescents’ health and care provisions in an increasingly digital society | 30 March 2023 | 19 Sep. 2023 11 April 2024 | two-stage | |
Validation of fluid-derived biomarkers for the prediction and prevention of brain disorders | 26 April 2023 | 19 Sep. 2023 11 April 2024 | two-stage | |
Tackling high-burden for patients, under-researched medical conditions | 26 April 2023 | 19 Sep. 2023 | two-stage | |
Access to health and care services for people in vulnerable situations | 30 March 2023 | 19 Sep. 2023 11 April 2024 | two-stage | |
Comparative effectiveness research for healthcare interventions in areas of high public health need | 26 April 2023 | 19 Sep. 2023 | two-stage | |
The role of environmental pollution in non-communicable diseases: air, noise and light and hazardous waste pollution | 30 March 2023 | 19 Sep. 2023 11 April 2024 | two-stage | |
Pandemic preparedness and response: Adaptive platform trials for pandemic preparedness | 26 April 2023 | 19 Sep. 2023 11 April 2024 | two-stage | |
Innovative non-animal human-based tools and strategies for biomedical research | 30 March 2023 | 19 Sep. 2023 11 April 2024 | two-stage | |
Personalised prevention of non-communicable diseases – addressing areas of unmet needs using multiple data sources | 30 March 2023 | 19 Sep. 2023 11 April 2024 | two-stage | |
Improving modes of delivery, deployment, and uptake of vaccines through phase IV/implementation research | 27 June 2023 | 28 Sep. 2023 03 April 2024 | two-stage | |
Advancing point-of-care diagnostics to the market | 27 June 2023 | 28 Sep. 2023 03 April 2024 | two-stage | |
Bio-printing of living cells for regenerative medicine | 26/10/2023 | 11/04/2024 | single-stage | |
Developing EU methodological frameworks for clinical/performance evaluation and post-market clinical/performance follow-up of medical devices and in vitro diagnostic medical devices (IVDs) | 26/10/2023 | 11/04/2024 | single-stage | |
Gaining experience and confidence in New Approach Methodologies (NAM) for regulatory safety and efficacy testing – coordinated training and experience exchange for regulators | 26/10/2023 | 11/04/2024 | single-stage | |
Pandemic preparedness and response: Maintaining the European partnership for pandemic preparedness | 26/10/2023 | 11/04/2024 | single-stage | |
Pandemic preparedness and response: Host-pathogen interactions of infectious diseases with epidemic potential | 26/10/2023 | 11/04/2024 | single-stage |
Ámbito: Europa
Presupuesto: 8.246 M€
Organismo: Comisión europea
Naturaleza de proyecto: I+D+i
BENEFICIARIO
Cualquier tipo de organización puede solicitar la financiación de Horizon Europe siempre que tenga la capacidad operativa y financiera para llevar a cabo las tareas que propone.
TIPO Y CUANTÍA DE LA FINANCIACIÓN
Variables
GASTOS FINANCIABLES
Costes directo e indirectos relacionados con el ámbito del programa.
Descubre lo que dicen de nuestro trabajo














